Neurogranin is a
calmodulin-binding protein expressed primarily in the brain, particularly in
dendritic spines, and participating in the
protein kinase C signaling pathway. Neurogranin has recently been found in aortic endothelial cells and cardiomyocytes.[5][6] Neurogranin is the main postsynaptic protein regulating the availability of calmodulin, binding to it in the absence of
calcium.
Phosphorylation by protein kinase C lowers its binding ability. NRGN gene expression is controlled by
thyroid hormones.[7] Human neurogranin consists of 78
amino acids.
One study tells of potential link of neurogranin gene to the heightened risk of
schizophrenia in males,[8] another study gives evidence of lowered neurogranin
immunoreactivity in the brains of people suffering from schizophrenia.[9]
Neurogranin concentration in
cerebrospinal fluid (CSF) is further discussed as marker for synaptic dysfunction in age-related neurodegeneration.[10] It has also been shown to be specifically increased in patients with
Alzheimer's disease.[11][12] Especially, the ratio of CSF neurogranin trunc P75 and the beta-secretase
BACE1 is suggested as a potential marker for cognitive deterioration in the progress of Alzheimer's disease.[13]
Prior to its identification in the bovine and
rat brain in 1991,[14] neurogranin was known as a putative protein kinase C-phosphorylated protein named p17. Human neurogranin was cloned in 1997 and turned out to be 96% identical to the rat protein.[15]
^Ruano D, Aulchenko YS, Macedo A, Soares MJ, Valente J, Azevedo MH, et al. (January 2008). "Association of the gene encoding neurogranin with schizophrenia in males". Journal of Psychiatric Research. 42 (2): 125–33.
doi:
10.1016/j.jpsychires.2006.10.008.
PMID17140601.
^Broadbelt K, Ramprasaud A, Jones LB (October 2006). "Evidence of altered neurogranin immunoreactivity in areas 9 and 32 of schizophrenic prefrontal cortex". Schizophrenia Research. 87 (1–3): 6–14.
doi:
10.1016/j.schres.2006.04.028.
PMID16797925.
S2CID38984915.
Neurogranin is a
calmodulin-binding protein expressed primarily in the brain, particularly in
dendritic spines, and participating in the
protein kinase C signaling pathway. Neurogranin has recently been found in aortic endothelial cells and cardiomyocytes.[5][6] Neurogranin is the main postsynaptic protein regulating the availability of calmodulin, binding to it in the absence of
calcium.
Phosphorylation by protein kinase C lowers its binding ability. NRGN gene expression is controlled by
thyroid hormones.[7] Human neurogranin consists of 78
amino acids.
One study tells of potential link of neurogranin gene to the heightened risk of
schizophrenia in males,[8] another study gives evidence of lowered neurogranin
immunoreactivity in the brains of people suffering from schizophrenia.[9]
Neurogranin concentration in
cerebrospinal fluid (CSF) is further discussed as marker for synaptic dysfunction in age-related neurodegeneration.[10] It has also been shown to be specifically increased in patients with
Alzheimer's disease.[11][12] Especially, the ratio of CSF neurogranin trunc P75 and the beta-secretase
BACE1 is suggested as a potential marker for cognitive deterioration in the progress of Alzheimer's disease.[13]
Prior to its identification in the bovine and
rat brain in 1991,[14] neurogranin was known as a putative protein kinase C-phosphorylated protein named p17. Human neurogranin was cloned in 1997 and turned out to be 96% identical to the rat protein.[15]
^Ruano D, Aulchenko YS, Macedo A, Soares MJ, Valente J, Azevedo MH, et al. (January 2008). "Association of the gene encoding neurogranin with schizophrenia in males". Journal of Psychiatric Research. 42 (2): 125–33.
doi:
10.1016/j.jpsychires.2006.10.008.
PMID17140601.
^Broadbelt K, Ramprasaud A, Jones LB (October 2006). "Evidence of altered neurogranin immunoreactivity in areas 9 and 32 of schizophrenic prefrontal cortex". Schizophrenia Research. 87 (1–3): 6–14.
doi:
10.1016/j.schres.2006.04.028.
PMID16797925.
S2CID38984915.